Loss of LYN Is Frequent in Targeted Therapy–Resistant Melanoma Cells and Favors Metastatic Properties-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Loss of LYN Is Frequent in Targeted Therapy–Resistant Melanoma Cells and Favors Metastatic Properties

Published:2024-07 Issue: Volume: Page:
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Gaudel Céline^ORCID,Pisibon Céline^ORCID,Soysouvanh Frédéric^ORCID,Giuliano Serena^ORCID,Picard-Gauci Alexandra^ORCID,Leclerc Justine^ORCID,Hofman Paul^ORCID,Bahadoran Philippe^ORCID,Bertolotto Corine^ORCID,Ballotti Robert^ORCID

Funder

INCa

Publisher

Elsevier BV

Reference12 articles.

1. The Src-family kinase Lyn in immunoreceptor signaling;Brian;Endocrinology,2021

2. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function;Brickell;Crit Rev Oncog,1992

3. Differential transformation capacity of Src family kinases during the initiation of prostate cancer;Cai;Proc Natl Acad Sci U S A,2011

4. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma;Falletta;Genes Dev,2017

5. Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma;Gangadhar;Invest New Drugs,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP